Analytik Jena AG:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Analytik Jena AG - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7469
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Analytik Jena AG (Analytik Jena), a subsidiary of Endress+Hauser AG is a provider of instruments and products for analytical measuring technology and life science. The company’s major products include atomic spectrometers, optical emission spectroscopy devices, mass spectrometers, mercury analyzers, UV/Vis spectrophotometers, sample preparation devices, TOC/TNb analyzers, AOX/TOX/EOX analyzers, elemental analyzers C/N/S/Cl, KF titrators, liquid handling systems, automated extraction systems, mixing and homogenization systems, general laboratory equipment , bioimaging systems and diagnostic kits and reagents. Analytik Jena also offers laboratory software management and information systems (LIMS), services, and consumables and disposables such as reagents and plastics. Its major customers include laboratory experts, natural preservation activists, anthropologists, biologists, evolution scientists, and other professional agencies. The company operates along with its subsidiaries in Germany, China, Japan, France, the US, the UK, Libya, Algeria, Thailand, and Romania. Analytik Jena is headquartered in Jena, Germany.

Analytik Jena AG – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Analytik Jena AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Analytik Jena AG, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Analytik Jena AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Analytik Jena AG, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Analytik Jena AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Analytik Jena AG, Medical Equipment, Deal Details 10
Partnerships 10
Analytik Jena Enters into Co-Development Agreement with Illumina 10
SIRS-Lab Plans To Enter Into Co-Marketing Agreement For Vyoo 11
Eppendorf Enters Into Licensing Agreement With Analytik Jena 12
Equity Offering 13
Analytik Jena Completes Rights Offering Of Shares For US$32.2 Million 13
Acquisition 14
Endress+Hauser Acquires Additional 10.69% Stake In Analytik Jena From Jens Adomat 14
Analytik Jena Acquires SIRS-Lab, Molecular Diagnostic Company 15
Analytik Jena Acquires UVP 17
Analytik Jena AG – Key Competitors 18
Analytik Jena AG – Key Employees 19
Analytik Jena AG – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 22
Strategy And Business Planning 22
Aug 17, 2017: TATAA Biocenter Expands Its Real-Time PCR Offerings With Analytik Jena’s qTOWER3 22
Corporate Communications 23
Mar 31, 2017: Company Founder and Analytik Jena Executive Board Member Klaus Berka Steps Down from the Operational Business 23
Product News 24
Apr 09, 2018: Analytik Jena Expands the Leading ICP-MS Series with a High-Performance Liquid Chromatography Module 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Analytik Jena AG, Medical Equipment, Key Facts 2
Analytik Jena AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Analytik Jena AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Analytik Jena AG, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Analytik Jena AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Analytik Jena AG, Deals By Market, 2012 to YTD 2018 8
Analytik Jena AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Analytik Jena Enters into Co-Development Agreement with Illumina 10
SIRS-Lab Plans To Enter Into Co-Marketing Agreement For Vyoo 11
Eppendorf Enters Into Licensing Agreement With Analytik Jena 12
Analytik Jena Completes Rights Offering Of Shares For US$32.2 Million 13
Endress+Hauser Acquires Additional 10.69% Stake In Analytik Jena From Jens Adomat 14
Analytik Jena Acquires SIRS-Lab, Molecular Diagnostic Company 15
Analytik Jena Acquires UVP 17
Analytik Jena AG, Key Competitors 18
Analytik Jena AG, Key Employees 19
Analytik Jena AG, Other Locations 20
Analytik Jena AG, Subsidiaries 21

List of Figures
Analytik Jena AG, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Analytik Jena AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Analytik Jena AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Analytik Jena AG, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Analytik Jena AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Analytik Jena AG, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Analytik Jena AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Analytik Jena AG, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Analytik Jena AG:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Pharmadax Inc (4191):製薬・医療:M&Aディール及び事業提携情報
    Summary Pharmadax Inc (Pharmadax) is a drug development and generic specialty pharmaceutical company. The company develops modified release generics in various therapeutic segments. It offers products such as glyburide, quetiapine fumarate ER and metoprolol succinate ER. Pharmadax provides in the pr …
  • Maxeda B.V.:企業の戦略・SWOT・財務情報
    Maxeda B.V. - Strategy, SWOT and Corporate Finance Report Summary Maxeda B.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Vyome Biosciences Pvt Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Vyome Biosciences Pvt Ltd (Vyome) is a clinical-stage biopharmaceutical company that develops novel drugs for antibiotic-resistant acne, other skin pathogens and anti-fungal agents in dermatology. The company’s pipeline products include VB 1953, VB 6345, VB 9333 and VB 9450. Its products are …
  • Tabuk Pharmaceuticals Manufacturing Company:製薬・医療:M&Aディール及び事業提携情報
    Summary Tabuk Pharmaceuticals Manufacturing Company (Tabuk), a subsidiary of Astra Industrial Group, is a drug company that develops, manufactures and markets branded generic pharmaceuticals and under-licensed products. The company offers products in various therapeutic areas including alimentary tr …
  • Jardine Cycle & Carriage Ltd (C07):企業の財務・戦略的SWOT分析
    Jardine Cycle & Carriage Ltd (C07) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • University of Dundee-製薬・医療分野:企業M&A・提携分析
    Summary University of Dundee (Dundee) is an educational research university that offers a range of undergraduate, postgraduate, postgraduate research degree, distant learning and English language programs. The university offers a wide range of academic and research courses in various disciplines suc …
  • Florida Power & Light Co:企業の発電所・SWOT分析2018
    Florida Power & Light Co - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key empl …
  • Nightingale Informatix Corp (NGH)-医療機器分野:企業M&A・提携分析
    Summary Nightingale Informatix Corp (Nightingale) is a healthcare technology company that develops, markets and licenses application software and related services. The company offers practice management, billing solutions, medical records and interoperability products. It provides web based document …
  • Genpact Ltd:企業の戦略・SWOT・財務情報
    Genpact Ltd - Strategy, SWOT and Corporate Finance Report Summary Genpact Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Bharat Dynamics Limited
    Bharat Dynamics Limited - Strategy, SWOT and Corporate Finance Report Summary Bharat Dynamics Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • TC Pipelines LP (TCP):企業の財務・戦略的SWOT分析
    Summary TC Pipelines LP (TC Pipelines) operates as an oil and gas company that manages natural gas pipelines and related assets. It offers development and operation of North American energy infrastructure including natural gas and liquids pipelines, power generation and gas storage facilities. It op …
  • Atkins Limited:企業のM&A・事業提携・投資動向
    Atkins Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Atkins Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • LUX Island Resorts Ltd:企業の戦略・SWOT・財務情報
    LUX Island Resorts Ltd - Strategy, SWOT and Corporate Finance Report Summary LUX Island Resorts Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • NIBC Bank NV:電力:M&Aディール及び事業提携情報
    Summary NIBC Bank NV (NIBC), a subsidiary of NIBC Holding NV, is an enterprising bank that provides a range of corporate and consumer banking services. The company specializes in mergers and acquisitions, debt and equity mezzanine, capitalization advisory, leveraged finance and structured finance, a …
  • The Jean Coutu Group (PJC) Inc.:戦略・SWOT・企業財務分析
    The Jean Coutu Group (PJC) Inc. - Strategy, SWOT and Corporate Finance Report Summary The Jean Coutu Group (PJC) Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Alabama Power Co:企業の発電所・SWOT分析2018
    Alabama Power Co - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (e …
  • Dah Chong Hong Holdings Ltd (1828):企業の財務・戦略的SWOT分析
    Dah Chong Hong Holdings Ltd (1828) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • 3D Oil Ltd (TDO):石油・ガス:M&Aディール及び事業提携情報
    Summary 3D Oil Ltd (3D Oil) is a producer and developer of oil and gas properties. The company’s products include natural gas and crude oil. It has interest in exploration permits in the offshore Gippsland and Otway Basins of South East Australia. 3D Oil's projects include T49-P located in offshore …
  • Mangalam Drugs and Organics Ltd (MANGALAM):企業の財務・戦略的SWOT分析
    Summary Mangalam Drugs and Organics Ltd (MDOL) carries out manufacturing and supplying of specialty chemicals, intermediates, and active pharmaceutical ingredients. The company's active pharmaceutical ingredients include amodiaquine HCl, bisoprolol fumarate, artemether, dihydroartemisinin, hydroxy c …
  • Kowa Co Ltd (7807):企業の財務・戦略的SWOT分析
    Kowa Co Ltd (7807) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆